106 related articles for article (PubMed ID: 30838095)
1. Correction:
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2019 Feb; 10(11):1225. PubMed ID: 30838095
[TBL] [Abstract][Full Text] [Related]
2.
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2018 Sep; 9(70):33368-33381. PubMed ID: 30279967
[TBL] [Abstract][Full Text] [Related]
3. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis.
Han BR; You BR; Park WH
Oncol Rep; 2013 Dec; 30(6):2999-3005. PubMed ID: 24064712
[TBL] [Abstract][Full Text] [Related]
5. Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2018 Dec; 9(102):37807. PubMed ID: 30701034
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid, a novel histone deacetylase inhibitor, improves the development and acetylation level of miniature porcine handmade cloning embryos.
Sun JM; Cui KQ; Li ZP; Lu XR; Xu ZF; Liu QY; Huang B; Shi DS
Reprod Domest Anim; 2017 Oct; 52(5):763-774. PubMed ID: 28432707
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.
Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB
J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid increases susceptibility to endotoxin shock through enhanced release of high-mobility group box 1.
Sugiura S; Ishihara Y; Komatsu T; Hagiwara M; Tanigawa N; Kato Y; Mizutani H; Kawahara K; Maruyama I; Noguchi T; Matsushita K
Shock; 2011 Nov; 36(5):494-500. PubMed ID: 21897334
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
Butt MU; Sailhamer EA; Li Y; Liu B; Shuja F; Velmahos GC; DeMoya M; King DR; Alam HB
J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
[TBL] [Abstract][Full Text] [Related]
12. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
13. DR396, an apoptotic DNase γ inhibitor, attenuates high mobility group box 1 release from apoptotic cells.
Yamada Y; Fujii T; Ishijima R; Tachibana H; Yokoue N; Takasawa R; Tanuma S
Bioorg Med Chem; 2011 Jan; 19(1):168-71. PubMed ID: 21167721
[TBL] [Abstract][Full Text] [Related]
14. Correction: Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.
Tsai MH; Liu JF; Chiang YC; Hu SC; Hsu LF; Lin YC; Lin ZC; Lee HC; Chen MC; Huang CL; Lee CW
Oncotarget; 2019 May; 10(36):3430. PubMed ID: 31448047
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy.
Veronezi GM; Felisbino MB; Gatti MS; Mello ML; Vidal BC
PLoS One; 2017; 12(1):e0170740. PubMed ID: 28114349
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
18. Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid.
Qiao L; Schaack J; Shao J
Endocrinology; 2006 Feb; 147(2):865-74. PubMed ID: 16282359
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock.
Dekker SE; Sillesen M; Bambakidis T; Andjelkovic AV; Jin G; Liu B; Boer C; Johansson PI; Linzel D; Halaweish I; Alam HB
J Surg Res; 2014 Jul; 190(1):312-8. PubMed ID: 24694719
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
